Skip to main content

Terunaga Nakagawa

The discovery of a ‘negative regulator’ in the brain alters understanding of brain function and potential treatment of cognitive disorders

Jul. 21, 2020—Terunaga Nakagawa and the Vanderbilt Brain Institute discover new qualities of GSG1L, responsible for activity in the anterior thalamus.

Read more


Study reveals mysteries of critical brain receptor complex

Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.

Read more


Grant bolsters Nakagawa’s research on autism, other brain disorders

Apr. 20, 2017—Terunaga Nakagawa, M.D., Ph.D., associate professor of Molecular Physiology and Biophysics, has received a two-year, $100,000 grant from the Brain and Behavior Research Foundation to continue his studies of the molecular underpinnings of autism and other brain disorders.

Read more


Study reveals neurotransmitter glutamate’s molecular structure

Aug. 11, 2016—Terunaga Nakagawa, with colleagues from Japan and Oxford University in England, has discovered the bridgelike molecular structure of a mysterious glutamate receptor.

Read more


VIEW MORE EVENTS >